Immunovant Inc (IMVT)

NASDAQ
18.20
+0.43(+2.42%)
After Hours
17.70
-0.50(-2.75%)
- Real-time Data
  • Volume:
    992,653
  • Day's Range:
    17.68 - 18.49
  • 52 wk Range:
    3.14 - 20.24
Earnings results expected tomorrow

Immunovant will announce its quarterly financial results tomorrow. Traders should take this into account as the share price often fluctuates around this time period.

IMVT Overview

Prev. Close
17.77
Day's Range
17.68-18.49
Revenue
-
Open
17.68
52 wk Range
3.14-20.24
EPS
-1.52
Volume
992,653
Market Cap
2.35B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,153,893
P/E Ratio
-12.03
Beta
1.26
1-Year Change
160.37%
Shares Outstanding
129,182,451
Next Earnings Date
03 Feb 2023
What is your sentiment on Immunovant?
or
Market is currently closed. Voting is open during market hours.

Immunovant Inc News

Immunovant Inc Analysis

Immunovant Inc Company Profile

Immunovant Inc Company Profile

Immunovant, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for patients with autoimmune diseases. The Company's product candidate, batoclimab, is a fully human, monoclonal antibody targeting the neonatal fragment crystallizable receptor. Batoclimab is a subcutaneous injection with dosing. Batoclimab is observed to reduce immunoglobulin G (IgG) antibodies that cause inflammation and disease. Its product candidate, batoclimab, is dosed in small volumes and with a 27-gauge needle. It is developing batoclimab for Myasthenia Gravis (MG), Thyroid Eye Disease (TED) and Warm Autoimmune Hemolytic Anemia (WAIHA). The Company is conducting a phase I drug-drug interaction (DDI) study in healthy volunteers to characterize the pharmacokinetic (PK) profile of atorvastatin with and without the coadministration of batoclimab.

Read More

Analyst Price Target

Average18.25 (+0.27% Upside)
High30.00
Low4.00
Price18.20
No. of Analysts8
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong BuyStrong BuyStrong BuyStrong Buy
SummarySellStrong BuyStrong BuyStrong BuyStrong Buy
  • Yess Green back. Bullish thanks you
    0